Profound Medical Corp. (PROF): Gross Profit
$11.39M
Year ended 2025-12-31
$13.70M
Trailing 12 months to 2026-06-30
| Period ended | Gross Profit | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $11.39M | +61.9% | 2026-03-05, From 2025-01-01 |
| 2024-12-31 | $7.04M | +63.2% | 2026-03-05, From 2024-01-01 |
| 2023-12-31 | $4.31M | n/a | 2025-03-07, From 2023-01-01 |
Gross Profit at similar companies
| Company | Year ended | Gross Profit | Change YoY |
|---|---|---|---|
| Profound Medical Corp. (PROF) | 2025-12-31 | $11.39M | +61.9% |
| Biotricity Inc. (BTCY) | 2026-03-31 | $12.95M | +22.6% |
| Allurion Technologies, Inc. (ALUR) | 2025-12-31 | $9.57M | -55.5% |
| Vivos Therapeutics, Inc. (VVOS) | 2025-12-31 | $10.54M | +16.9% |
| Nephros Inc (NEPH) | 2025-12-31 | $11.62M | +33.3% |
| Sonoma Pharmaceuticals, Inc. (SNOA) | 2026-03-31 | $7.42M | +35.7% |
| Spectral AI, Inc. (MDAI) | 2025-12-31 | $8.93M | -32.8% |
| DarioHealth Corp. (DRIO) | 2025-12-31 | $12.66M | -4.5% |
| Baird Medical Investment Holdings Ltd (BDMD) | 2025-12-31 | $18.88M | -42.2% |
Compare PROF, BTCY, ALUR, VVOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗